Causes of Death Among Patients With Initially Inoperable Pancreas Cancer After Induction Chemotherapy and Ablative 5-fraction Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy
Purpose: Nearly all patients with pancreatic ductal adenocarcinoma (PDAC) eventually die of progressive cancer after exhausting treatment options. Although distant metastases (DMs) are a common cause of death, autopsy studies have shown that locoregional progression may be directly responsible for u...
Main Authors: | Michael D. Chuong, MD, Roberto Herrera, BS, Antonio Ucar, MD, Santiago Aparo, MD, Fernando De Zarraga, MD, Horacio Asbun, MD, Ramon Jimenez, MD, Domenech Asbun, MD, Govindarajan Narayanan, MD, Sarah Joseph, MD, Rupesh Kotecha, MD, Matthew D. Hall, MD, MBA, Kathryn M. Mittauer, PhD, Diane Alvarez, MSc, James McCulloch, DMP, Tino Romaguera, PhD, Alonso Gutierrez, PhD, MBA, Adeel Kaiser, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Advances in Radiation Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452109422001907 |
Similar Items
-
Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer
by: Michael D. Chuong, et al.
Published: (2022-06-01) -
Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy10 for Non-bone Oligometastases
by: Tugce Kutuk, MD, et al.
Published: (2022-11-01) -
Dose-Escalated Magnetic Resonance Image–Guided Abdominopelvic Reirradiation With Continuous Intrafraction Visualization, Soft Tissue Tracking, and Automatic Beam Gating
by: Michael D. Chuong, MD, et al.
Published: (2022-03-01) -
Ablative Five-Fraction Stereotactic Body Radiation Therapy for Inoperable Pancreatic Cancer Using Online MR-Guided Adaptation
by: Comron Hassanzadeh, MD, MPH, et al.
Published: (2021-01-01) -
A case of improved quality of life in a patient with inoperable pancreatic cancer after repeated RFA
by: Nino Toria, MD, et al.
Published: (2022-10-01)